These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1725366)

  • 41. Effects of nisoldipine upon vasoconstrictor responses and binding of endothelin-1 in ischemic and reperfused rat hearts.
    Watts JA; Chapat S; Johnson DE; Janis RA
    J Cardiovasc Pharmacol; 1992 Jun; 19(6):929-36. PubMed ID: 1376815
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of influence of 24-hour cold preservation on endothelin production and on endothelin receptors in the bone vasculature.
    Coessens BC; Adams ML; Wood MB
    J Orthop Res; 1995 Sep; 13(5):725-32. PubMed ID: 7472751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for a direct vasoconstrictor effect of big endothelin-1 in the rat kidney.
    Salvati P; Dho L; Calabresi M; Rosa B; Patrono C
    Eur J Pharmacol; 1992 Oct; 221(2-3):267-73. PubMed ID: 1426005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of chloride channel blockers on rat renal vascular responses to angiotensin II and norepinephrine.
    Steendahl J; Holstein-Rathlou NH; Sorensen CM; Salomonsson M
    Am J Physiol Renal Physiol; 2004 Feb; 286(2):F323-30. PubMed ID: 14506073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characteristics of endothelin A and B binding sites and their vascular effects in pig peripheral tissues.
    Hemsén A; Larsson O; Lundberg JM
    Eur J Pharmacol; 1991 Dec; 208(4):313-22. PubMed ID: 1667759
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction between thromboxane A2 and angiotensin II in postischemic renal vasoconstriction in dogs.
    Abels BC; Branch RA; Sabra R
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1285-92. PubMed ID: 8450463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries.
    Dohi Y; Hahn AW; Boulanger CM; Bühler FR; Lüscher TF
    Hypertension; 1992 Feb; 19(2):131-7. PubMed ID: 1737646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Big ET-1 infusion in man causes renal ET-1 release, renal and splanchnic vasoconstriction, and increased mean arterial blood pressure.
    Ahlborg G; Ottosson-Seeberger A; Hemsén A; Lundberg JM
    Cardiovasc Res; 1994 Oct; 28(10):1559-63. PubMed ID: 8001046
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of protein intake on regional vascular resistance and reactivity to angiotensin II in the rat.
    Murray BM
    Circ Res; 1990 Aug; 67(2):440-7. PubMed ID: 2198116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endothelin-1-induced renal vasoconstriction is blunted by enalaprilat and enhanced by EDRF antagonist in awake normotensive rats.
    Madeddu P; Anania V; Parpaglia PP; Troffa C; Pazzola A; Soro A; Manunta P; Tonolo G; Demontis MP; Varoni MV
    Clin Invest Med; 1991 Dec; 14(6):600-6. PubMed ID: 1665404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced renal vasoconstriction in rats fed essential fatty acid-deficient diet.
    Sakr HM; Dunham EW
    Am J Physiol; 1982 Jul; 243(1):H61-7. PubMed ID: 6807110
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic vasoconstriction modulates the responses of pulmonary vasculature and airway to vasoconstrictors in anesthetized rats.
    Wang M; Shibamoto T; Kuda Y; Tanida M; Kurata Y
    Exp Lung Res; 2015; 41(6):324-34. PubMed ID: 26151368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Local angiotensin-converting enzyme inhibition blunts endothelin-1-induced increase in forearm vascular resistance.
    Abernethy DR; Laurie N; Andrawis NS
    Clin Pharmacol Ther; 1995 Sep; 58(3):328-34. PubMed ID: 7554707
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal ischemia-reperfusion injury: contribution of nitric oxide and renal blood flow.
    Mashiach E; Sela S; Winaver J; Shasha SM; Kristal B
    Nephron; 1998 Dec; 80(4):458-67. PubMed ID: 9832646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacology of endothelin-1 in vivo in humans.
    Haynes WG; Clarke JG; Cockcroft JR; Webb DJ
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S284-6. PubMed ID: 1725356
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelin induces an increase in renal vascular resistance and a fall in glomerular filtration rate in the rabbit isolated perfused kidney.
    Cairns HS; Rogerson ME; Fairbanks LD; Neild GH; Westwick J
    Br J Pharmacol; 1989 Sep; 98(1):155-60. PubMed ID: 2679955
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of nitric oxide contributes to vasospasm during ischemia/reperfusion injury.
    Wang WZ; Anderson G; Fleming JT; Peter FW; Franken RJ; Acland RD; Barker J
    Plast Reconstr Surg; 1997 Apr; 99(4):1099-108. PubMed ID: 9091909
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclosporine augments renal but not systemic vascular reactivity.
    Garr MD; Paller MS
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F211-7. PubMed ID: 2301592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ischemia-reperfusion increases gastric motility and endothelin-1-induced vasoconstriction.
    Wood JG; Yan ZY; Zhang Q; Cheung LY
    Am J Physiol; 1995 Oct; 269(4 Pt 1):G524-31. PubMed ID: 7485504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exogenous endothelin-1 causes renal vasodilation in the fetal lamb.
    Bogaert GA; Kogan BA; Mevorach RA; Wong J; Gluckman GR; Fineman JR; Heymann MA
    J Urol; 1996 Aug; 156(2 Pt 2):847-53. PubMed ID: 8683799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.